Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
194.55
2.51 (1.31%)
At close: Aug 15, 2025, 10:15 AM
1.31%
Bid 191.54
Market Cap 11.78B
Revenue (ttm) 368.7M
Net Income (ttm) -341.67M
EPS (ttm) -5.27
PE Ratio (ttm) -36.92
Forward PE 86.66
Analyst Buy
Ask 196.52
Volume 38,942
Avg. Volume (20D) 469,491
Open 190.78
Previous Close 192.04
Day's Range 190.38 - 194.75
52-Week Range 111.09 - 199.99
Beta 0.40

About ASND

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ASND
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ASND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Ascendis Pharma A/S has released their quartely earnings on Aug 7, 2025:
  • Revenue of $179.22M exceeds estimates by $16.41M, with 362.44% YoY growth.
  • EPS of -0.93 exceeds estimates by 0.49, with 54.85% YoY growth.
  • Next Earnings Release

    Ascendis Pharma A/S is scheduled to release its earnings on Nov 13, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    6 days ago
    +0.6%
    Acendis Pharma shares are trading lower following ... Unlock content with Pro Subscription
    2 weeks ago
    +4.03%
    Ascendis Pharma shares are trading higher after JP Morgan raised its price target on the stock from $245 to $254.